Management of endocrine disease: Imaging for the diagnosis of malignancy in incidentally discovered adrenal masses: a systematic review and meta-analysis

Research output: Contribution to journalArticle

Authors

External organisations

  • Department of Imaging, St Bartholomew's Hospital, Barts Health, London, EC1A 7BE
  • Departments of Radiology Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TT, UK
  • Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital Wurzburg, University of Wurzburg, 97080 Wurzburg, Germany

Abstract

Objective: Adrenal masses are incidentally discovered in 5% of CT scans. In 2013/2014, 81 million CT examinations were undertaken in the USA and 5 million in the UK. However, uncertainty remains around the optimal imaging approach for diagnosing malignancy. We aimed to review the evidence on the accuracy of imaging tests for differentiating malignant from benign adrenal masses. Design: Systematic review and meta-analysis Methods: We searched MEDLINE, EMBASE, Cochrane CENTRAL Register of Controlled Trials, Science Citation Index, Conference Proceedings Citation Index, and ZETOC (January 1990 to August 2015). We included studies evaluating the accuracy of CT, MRI or FDG-PET compared to an adequate histological or imaging-based follow-up reference standard. Results: We identified 37 studies suitable for inclusion, after screening 5469 references and 525 full-text articles. Studies evaluated the accuracy of CT (n=16), MRI (n=15) and FDG-PET (n=9) and were generally small and at high or unclear risk of bias. Only 19 studies were eligible for meta-analysis. Limited data suggest that CT density >10HU has high sensitivity for detection of adrenal malignancy in participants with no prior indication for adrenal imaging, i.e. masses with ≤10HU are unlikely to be malignant. All other estimates of test performance are based on too small numbers. Conclusions: Despite its widespread use in routine assessment, there is insufficient evidence for the diagnostic value of individual imaging tests in distinguishing benign from malignant adrenal masses. Future research is urgently needed and should include prospective test validation studies for imaging and novel diagnostic approaches alongside detailed health economics analysis.

Details

Original languageEnglish
Pages (from-to)R51-R64
JournalEuropean Journal of Endocrinology
Volume175
Early online date2 Jun 2016
Publication statusPublished - 1 Aug 2016

Keywords

  • Imaging, adrenal mass, systematic review, diagnostic accuracy, adrenal malignancy